Similar Items: Eligibility for anti‐amyloid treatment in a multiethnic community‐based study
- Anti‐amyloid therapy eligibility in a longitudinal brain‐donor cohort with post mortem confirmation
- Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
- Anti‐amyloid nanobody‐Fc fusion protein drives potent amyloid clearance through microglial recruitment
- White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
- Obstacles and solutions for implementing amyloid‐targeting treatments in Europe
- Performing multiple biomarker tests delays initiation of amyloid‐targeting treatments